These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 618413)

  • 1. Lymphocyte populations and cellular immune reactions in vitro in patients with multiple sclerosis.
    Nordal HJ; Froland SS
    Clin Immunol Immunopathol; 1978 Jan; 9(1):87-96. PubMed ID: 618413
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphocyte sensitivity to phytohemagglutin (PHA) and pokeweed mitogen (PWM) in patients with multiple sclerosis].
    Czernicki J; Chmielewski H; Jurkowski A
    Pol Tyg Lek; 1974 May; 29(21):881-3. PubMed ID: 4840200
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphotoxic activity in multiple sclerosis serum.
    Van den Noort S; Stjernholm RL
    Neurology; 1971 Aug; 21(8):783-93. PubMed ID: 5106294
    [No Abstract]   [Full Text] [Related]  

  • 4. Measles-adherent lymphocyte phenomenon of Levy in multiple sclerosis: normal reactivity of blood lymphocytes.
    Kinnman J; Link H
    Acta Neurol Scand; 1979 May; 59(5):241-7. PubMed ID: 314219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspects of humoral and cellular immunity in schizophrenia.
    Vartanian ME; Kolyaskina GI; Lozovsky DV; Burbaeva GS; Ignatov SA
    Birth Defects Orig Artic Ser; 1978; 14(5):339-64. PubMed ID: 80239
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular immunity in multiple sclerosis.
    Knight SC
    Br Med Bull; 1977 Jan; 33(1):45-50. PubMed ID: 137763
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocyte transformation induced in vitro by PHA and PPD in multiple sclerosis.
    Cendrowski W; Niedzielska K
    J Neurol Neurosurg Psychiatry; 1970 Feb; 33(1):92-4. PubMed ID: 5418184
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological assessment in sporadic amyotrophic lateral sclerosis (ALS).
    Provinciali L; Giovagnoli AR; Battucci S; Bartocci C; Montroni M
    Adv Exp Med Biol; 1987; 209():149-53. PubMed ID: 3577904
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporin A inhibits ganglioside-stimulated lymphocyte rosette formation in multiple sclerosis.
    Davison AN; Ilyas AA
    Int Arch Allergy Appl Immunol; 1982; 69(4):393-6. PubMed ID: 7141720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological reactions against Mycoplasma pneumoniae in multiple sclerosis: preliminary findings.
    Maida E
    J Neurol; 1983; 229(2):103-11. PubMed ID: 6190995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of immunological parameters in multiple sclerosis: cell-mediated immunity and complement profiles.
    Mar P; Gradl T; Dörner C; Contag I
    Clin Exp Immunol; 1979 Jun; 36(3):442-8. PubMed ID: 487645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of cellular immunity in multiple sclerosis].
    Demina TL; Boĭko AN; Balashov KE; Pinegin BV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):35-41. PubMed ID: 2524943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response of lymphocytes from patients with multiple sclerosis to phytohemagglutinin, basic protein of myelin and measles antigens.
    Offner H; Ammitzboll T; Clausen J; Fog T; Hyllested K; Einstein E
    Acta Neurol Scand; 1974; 50(3):373-81. PubMed ID: 4275640
    [No Abstract]   [Full Text] [Related]  

  • 14. Transformation of lymphocytes from patients with multiple sclerosis. Use of encephalitogen of human origin, with a report of a trial of immunosuppressive therapy in multiple sclerosis.
    Dau PC; Peterson RD
    Arch Neurol; 1970 Jul; 23(1):32-40. PubMed ID: 5421929
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular immunology in multiple sclerosis. A review through 1984.
    Baumhefner RW; Tourtellotte WW
    Concepts Immunopathol; 1985; 2():151-88. PubMed ID: 2439204
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated immune functions in multiple sclerosis.
    O'Gorman M; Oger J
    Pathol Immunopathol Res; 1987; 6(4):241-72. PubMed ID: 3329340
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of formation of active T-rosette forming cells in multiple sclerosis patients].
    Matveeva TV; D'iakonova IN; Shaĭdullina FS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):21-5. PubMed ID: 6972132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of lymphocyte-mediated cytotoxicity after tumor resection in patients with colorectal cancer.
    Waller CA; Gill PG; MacLennan IC
    J Natl Cancer Inst; 1980 Aug; 65(2):223-30. PubMed ID: 6931244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte-mediated cytotoxicity to viruses in patients with multiple sclerosis: presence of a blocking factor.
    Rola-Pleszczynski M; Abernathy M; Vincent MM; Hensen SA; Bellanti JA
    Clin Immunol Immunopathol; 1976 Mar; 5(2):165-72. PubMed ID: 1084246
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandin E inhibition of mitogen stimulation in patients with multiple sclerosis.
    Goodwin JS; Messner RP
    Prostaglandins; 1978 Feb; 15(2):281-6. PubMed ID: 635219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.